Telehealth company Hims & Hers stirred up controversy by debuting a 2025 Super Bowl ad touting the benefits of its ...

The data, published in JAMA Psychiatry, add to the growing body of evidence supporting the use of GLP-1 receptor agonists for ...

The Danish maker of Ozempic and Wegovy reported a 25 percent increase in sales to $40.6 billion, but said it expected slower ...

Novo Nordisk already has approval for semaglutide under the Wegovy brand for obesity, while Lilly is in the process of seeking approval to add weight loss to the label of Mounjaro. Both drugs are ...

The list of 15 medicines includes blockbuster drugs from Novo Nordisk, Pfizer, Bristol Myers Squibb, AstraZeneca, GSK and other companies. Novo’s booming semaglutide franchise for diabetes and ...

The CMS listed Ozempic, Rybelsus and Wegovy — all forms of semaglutide — at the top ... in the U.S. Danish pharmaceutical giant Novo Nordisk is the manufacturer of Ozemipc; its diabetes ...